Search Results - "Howaidi, Jude"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study by Awwad, Sameh, Abu Alnasr, Rawan, Almanjomi, Fahad, Al Sultan, Murtada, Howaidi, Jude, Almotairi, Mohammed, AlFayyad, Issam

    Published in Pediatric hematology oncology journal (01-03-2024)
    “…Leukemia is the most prevalent type of cancer affecting children, representing approximately 35% of cancer diagnoses in Saudi Arabia. Notably, significant…”
    Get full text
    Journal Article
  4. 4

    Clustered regularly interspaced short palindromic repeats-Cas9 gene therapy: The top 50 most-cited papers by Jude Howaidi, Ali Howaidi, Faisal Howaidi

    Published in Journal of nature and science of medicine (01-01-2019)
    “…Background: Clustered regularly interspaced short palindromic repeats/Cas9 (CRISPR/Cas9) is a gene-editing technique that creates advancement in biomedical…”
    Get full text
    Journal Article
  5. 5

    Health-related quality of life of breast and colorectal cancer patients undergoing active chemotherapy treatment: Patient-reported outcomes by AlFayyad, Isamme, Al-Tannir, Mohamad, Howaidi, Jude, AlTannir, Dana, Abu-Shaheen, Amani

    Published in Quality of life research (01-09-2022)
    “…Purpose We sought to explore the Health-Related Quality of Life (HRQoL) of Breast Cancer (BC) and Colorectal Cancer (CRC) patients receiving active…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience by Alrajhi, Abdullah M., Alrouqi, Mashael, Howaidi, Jude, Alwadi, Mohammmad, Alshehri, Hassan, Tailor, Imran K, Alnoamani, Mohammed S, Alshehry, Nawal F, Motabi, Ibraheem H, Marei, Mohammed A, Alhumaid, Muhned

    Published in Blood (02-11-2023)
    “…Background Over the past few decades, the outcomes for children with ALL have significantly improved with current regimens that yield a 5-year complete…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Use of thrombopoietin receptor agonists in pregnancy: A review of the literature by Howaidi, Jude, AlRajhi, Abdullah M., Howaidi, Ali, AlNajjar, Fouad H., Tailor, Imran K.

    Published in Hematology/oncology and stem cell therapy (01-03-2022)
    “…The management of immune thrombocytopenic purpura (ITP) involves several lines of therapy such as corticosteroids and intravenous immunoglobulin. With the…”
    Get full text
    Journal Article